Clinical Features
Our experience implementing the National Cancer Information System (NCIS) in Galway University Hospitals
Written by Peter Kidd, National Cancer Information System Project Manager, Galway University Hospitals Introduction: what is NCIS? The National Cancer
Clinical
Our experience implementing the National Cancer Information System (NCIS) in Galway University Hospitals
Written by Peter Kidd, National Cancer Information System Project Manager, Galway University Hospitals Introduction: what is NCIS? The National Cancer
Product News
Darzalex ®▼ (daratumumab) approved for reimbursement in Ireland in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible
Approval is based on data from the Phase 3 CASSIOPEIA trial, which demonstrated that the addition of daratumumab resulted in
Innovation
Discharge Medication (TTO) Service: Bridging the Gap
Written by Patrick Foley, Head of Pharmacy, Blackrock Health at The Hermitage Clinic Summary The philosophy of the Hermitage Clinic
